521 related articles for article (PubMed ID: 28153433)
1. Thrombocytopenia as a thrombotic risk factor in patients with antiphospholipid antibodies without disease criteria.
Demetrio Pablo R; Muñoz P; López-Hoyos M; Calvo V; Riancho L; Martínez-Taboada VM
Med Clin (Barc); 2017 May; 148(9):394-400. PubMed ID: 28153433
[TBL] [Abstract][Full Text] [Related]
2. Thrombotic risk stratification by platelet count in patients with antiphospholipid antibodies: a longitudinal study.
Hisada R; Kato M; Sugawara E; Fujieda Y; Oku K; Bohgaki T; Amengual O; Yasuda S; Atsumi T
J Thromb Haemost; 2017 Sep; 15(9):1782-1787. PubMed ID: 28662299
[TBL] [Abstract][Full Text] [Related]
3. Length of exposure to antiphospholipid antibodies, rather than age, is a risk factor for thrombosis: a retrospective single-centre observational study.
Les I; Parraza N; Anaut P; Eguiluz S; Sánchez C; Preciado ME; Loza JÁ; Andía A
Rheumatol Int; 2018 Feb; 38(2):229-238. PubMed ID: 29124399
[TBL] [Abstract][Full Text] [Related]
4. Thrombotic risk in patients with immune thrombocytopenia and its association with antiphospholipid antibodies.
Kim KJ; Baek IW; Yoon CH; Kim WU; Cho CS
Br J Haematol; 2013 Jun; 161(5):706-714. PubMed ID: 23530551
[TBL] [Abstract][Full Text] [Related]
5. Serological evolution in women with positive antiphospholipid antibodies.
Riancho-Zarrabeitia L; Daroca G; Muñoz P; López-Hoyos M; Haya A; Martínez-Taboada VM
Semin Arthritis Rheum; 2017 Dec; 47(3):397-402. PubMed ID: 28576307
[TBL] [Abstract][Full Text] [Related]
6. Risk Factors for the Development of the Disease in Antiphospholipid Antibodies Carriers: A Long-term Follow-up Study.
Pablo RD; Cacho PM; López-Hoyos M; Calvo-Río V; Riancho-Zarrabeitia L; Martínez-Taboada VM
Clin Rev Allergy Immunol; 2022 Apr; 62(2):354-362. PubMed ID: 34216367
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of the antiphospholipid score for the diagnosis of antiphospholipid syndrome and its predictive value for thrombotic events.
Otomo K; Atsumi T; Amengual O; Fujieda Y; Kato M; Oku K; Horita T; Yasuda S; Koike T
Arthritis Rheum; 2012 Feb; 64(2):504-12. PubMed ID: 21953404
[TBL] [Abstract][Full Text] [Related]
8. Persistent triple antiphospholipid antibody positivity as a strong risk factor of first thrombosis, in a long-term follow-up study of patients without history of thrombosis or obstetrical morbidity.
Yelnik CM; Urbanski G; Drumez E; Sobanski V; Maillard H; Lanteri A; Morell-Dubois S; Caron C; Dubucquoi S; Launay D; Duhamel A; Hachulla E; Hatron PY; Lambert M
Lupus; 2017 Feb; 26(2):163-169. PubMed ID: 27432808
[TBL] [Abstract][Full Text] [Related]
9. The emerging role of multiple antiphospholipid antibodies positivity in patients with antiphospholipid syndrome.
Forastiero R; Martinuzzo M
Expert Rev Clin Immunol; 2015; 11(11):1255-63. PubMed ID: 26295486
[TBL] [Abstract][Full Text] [Related]
10. Persistent antiphospholipid antibody (aPL) in asymptomatic carriers as a risk factor for future thrombotic events: a nationwide prospective study.
Mustonen P; Lehtonen KV; Javela K; Puurunen M
Lupus; 2014 Dec; 23(14):1468-76. PubMed ID: 25164304
[TBL] [Abstract][Full Text] [Related]
11. [Antiphospholipid antibodies and the risk of thrombosis: a comparative survey between chronic immune thrombocytopenia and primary antiphospholipid syndrome].
Moulis G; Delavigne K; Huguet F; Fortenfant F; Beyne-Rauzy O; Adoue D
Rev Med Interne; 2011 Dec; 32(12):724-9. PubMed ID: 21864953
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of anti-domain 1 β2-glycoprotein I antibodies in antiphospholipid syndrome.
Iwaniec T; Kaczor MP; Celińska-Löwenhoff M; Polański S; Musiał J
Thromb Res; 2017 May; 153():90-94. PubMed ID: 28363116
[TBL] [Abstract][Full Text] [Related]
13. The adjusted global antiphospholipid syndrome score (aGAPSS) and the risk of recurrent thrombosis: Results from the APS ACTION cohort.
Radin M; Sciascia S; Erkan D; Pengo V; Tektonidou MG; Ugarte A; Meroni P; Ji L; Belmont HM; Cohen H; Ramires de Jesús G; Branch DW; Fortin PR; Andreoli L; Petri M; Rodriguez E; Rodriguez-Pinto I; Knight JS; Atsumi T; Willis R; Gonzalez E; Lopez-Pedrera R; Rossi Gandara AP; Borges Gualhardo Vendramini M; Banzato A; Sevim E; Barbhaiya M; Efthymiou M; Mackie I; Bertolaccini ML; Andrade D;
Semin Arthritis Rheum; 2019 Dec; 49(3):464-468. PubMed ID: 31153708
[TBL] [Abstract][Full Text] [Related]
14. [Clinical significance of antiphospholipid antibody in pediatric patients and review of literature].
Xiao HJ; Yang JY; Gao TJ; Huang JP; Yao Y; Zhang Y
Zhonghua Er Ke Za Zhi; 2004 Aug; 42(8):571-3. PubMed ID: 15347440
[TBL] [Abstract][Full Text] [Related]
15. Antiphospholipid syndrome without antiphospholipid antibodies at the time of the thrombotic event: transient 'seronegative' antiphospholipid syndrome?
Miret C; Cervera R; Reverter JC; García-Carrasco M; Ramos M; Mollà M; Font J; Ingelmo M
Clin Exp Rheumatol; 1997; 15(5):541-4. PubMed ID: 9307863
[TBL] [Abstract][Full Text] [Related]
16. Antiphospholipid antibodies in neonates with stroke--a unique entity or variant of antiphospholipid syndrome?
Berkun Y; Simchen MJ; Strauss T; Menashcu S; Padeh S; Kenet G
Lupus; 2014 Sep; 23(10):986-93. PubMed ID: 24729280
[TBL] [Abstract][Full Text] [Related]
17. Homocysteine, antiphospholipid antibodies and risk of thrombosis in patients with systemic lupus erythematosus.
Martínez-Berriotxoa A; Ruiz-Irastorza G; Egurbide MV; Rueda M; Aguirre C
Lupus; 2004; 13(12):927-33. PubMed ID: 15645748
[TBL] [Abstract][Full Text] [Related]
18. Analysis of risk factors for the development of thrombotic complications in antiphospholipid antibody positive lupus patients.
Tarr T; Lakos G; Bhattoa HP; Shoenfeld Y; Szegedi G; Kiss E
Lupus; 2007; 16(1):39-45. PubMed ID: 17283584
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis and classification of the antiphospholipid syndrome.
Gómez-Puerta JA; Cervera R
J Autoimmun; 2014; 48-49():20-5. PubMed ID: 24461539
[TBL] [Abstract][Full Text] [Related]
20. Clinical profiles and risk assessment in patients with antiphospholipid antibodies.
Kato M; Hisada R; Atsumi T
Expert Rev Clin Immunol; 2019 Jan; 15(1):73-81. PubMed ID: 30381978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
